Dye Sensitizers for Photodynamic Therapy
Photofrin® was first approved in the 1990s as a sensitizer for use in treating cancer via photodynamic therapy (PDT). Since then a wide variety of dye sensitizers have been developed and a few have been approved for PDT treatment of skin and organ cancers and skin diseases such as acne vulgaris. Por...
Main Authors: | Harold S. Freeman, Alexandra B. Ormond |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-03-01
|
Series: | Materials |
Subjects: | |
Online Access: | http://www.mdpi.com/1996-1944/6/3/817 |
Similar Items
-
Clinical development of photodynamic agents and therapeutic applications
by: Rengarajan Baskaran, et al.
Published: (2018-09-01) -
Photosensitizers-Loaded Nanocarriers for Enhancement of Photodynamic Therapy in Melanoma Treatment
by: Ana Maria Udrea, et al.
Published: (2023-08-01) -
Development of Novel Tetrapyrrole Structure Photosensitizers for Cancer Photodynamic Therapy
by: Natalia Plekhova, et al.
Published: (2022-02-01) -
Photodynamic Therapy for Glioblastoma: Illuminating the Path toward Clinical Applicability
by: Debarati Bhanja, et al.
Published: (2023-06-01) -
Cationic Porphyrins as Antimicrobial and Antiviral Agents in Photodynamic Therapy
by: Inga O. Savelyeva, et al.
Published: (2023-12-01)